Skip to main content

Marta González Sepúlveda

Institutions of which they are part

Postdoctoral researcher
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Marta González Sepúlveda

Institutions of which they are part

Postdoctoral researcher
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Projects

Modulation of age-dependent neuromelanin accumulation as a novel therapeutic strategy for Parkinson’s disease and brain aging

IP: Miquel Vila Bover
Collaborators: Ariadna Laguna Tuset, Modulation of age-dependent neuromelanin accumulation as a novel therapeutic strategy for Parkinson’s disease and brain aging, Marta González Sepúlveda, Annabelle Parent
Funding agency: Fundació "La Caixa"
Funding: 466004
Reference: FBLC/HR17-00513/VILA
Duration: 01/09/2018 - 05/01/2022

Related news

The initiative seeks to raise awareness of the disease and promote the well-being of those affected, while fostering empathy and scientific vocations among young people.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

Related professionals

Marian Del Hoyo Martín

Marian Del Hoyo Martín

Research technician
Psychiatry, Mental Health and Addictions
Read more
Carlos Alcoleba García

Carlos Alcoleba García

General Surgery
Read more
Laura Doménech Moral

Laura Doménech Moral

Main researcher
Basic, Translational and Clinical Pharmacy Research
Read more
Iratxe Ugarriza Serrano

Iratxe Ugarriza Serrano

Neurovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.